Cartesian Therapeutics (RNAC) Change in Account Payables (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Change in Account Payables of $310000.0 for Q1 2026, down 82.96% year-over-year from $1.8 million in Q1 2025, and up 133.23% on a QoQ basis from -$933000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) has 12 years of Change in Account Payables data on file, last reported at $310000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 82.96% year-over-year to $310000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$443000.0 (up 6.74% YoY) and the FY2025 annual result came in at $1.1 million, up 136.42% from the prior year.
- Change in Account Payables rose to $310000.0 in Q1 2026 per RNAC's latest filing, from -$933000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q4 2023 and bottomed at -$2.4 million in Q3 2024.
- The 5-year median for Change in Account Payables is $85000.0 (2023), against an average of $80882.4.
- The widest annual swing landed in 2023, when Change in Account Payables soared 4050.0%; it then sank 2923.53% in 2024.
- Tracing RNAC's Change in Account Payables over 5 years: stood at $102000.0 in 2022, then jumped by 2643.14% to $2.8 million in 2023, then sank by 108.47% to -$237000.0 in 2024, then plunged by 293.67% to -$933000.0 in 2025, then soared by 133.23% to $310000.0 in 2026.
- Per Business Quant, the three latest RNAC Change in Account Payables figures stand at $310000.0 (Q1 2026), -$933000.0 (Q4 2025), and $1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Cartesian Therapeutics | 202.49 Mn | 202.49 Mn | - | 310,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,000.00 |
| Mar 31, 2026 | 310,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | -237,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 343,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 85,000.00 |
| Sep 30, 2023 | 85,000.00 |
| Jun 30, 2023 | -796,000.00 |
| Jun 30, 2023 | -796,000.00 |
| Mar 31, 2023 | 747,000.00 |
| Mar 31, 2023 | 747,000.00 |
| Dec 31, 2022 | 102,000.00 |
| Dec 31, 2022 | 102,000.00 |
| Sep 30, 2022 | -310,000.00 |
| Sep 30, 2022 | -310,000.00 |
| Jun 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 282,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | -1.37 Mn |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | -440,000.00 |
| Jun 30, 2021 | -440,000.00 |
| Mar 31, 2021 | 151,000.00 |
| Mar 31, 2021 | 151,000.00 |
| Dec 31, 2020 | -28,000.00 |
| Dec 31, 2020 | -28,000.00 |
| Sep 30, 2020 | -764,000.00 |
| Sep 30, 2020 | -764,000.00 |
| Jun 30, 2020 | -101,000.00 |
| Jun 30, 2020 | -101,000.00 |
| Mar 31, 2020 | 836,000.00 |
| Mar 31, 2020 | 836,000.00 |
| Dec 31, 2019 | -978,000.00 |
| Dec 31, 2019 | -978,000.00 |
| Sep 30, 2019 | -985,000.00 |
| Sep 30, 2019 | -985,000.00 |
| Jun 30, 2019 | 1.77 Mn |
| Jun 30, 2019 | 1.77 Mn |
| Mar 31, 2019 | -407,000.00 |
| Mar 31, 2019 | -407,000.00 |
| Dec 31, 2018 | -147,000.00 |
| Dec 31, 2018 | -147,000.00 |
| Sep 30, 2018 | -524,000.00 |
| Sep 30, 2018 | -524,000.00 |
| Jun 30, 2018 | -25,000.00 |
| Jun 30, 2018 | -25,000.00 |
| Mar 31, 2018 | 180,000.00 |
| Mar 31, 2018 | 180,000.00 |
| Dec 31, 2017 | 72,000.00 |
| Dec 31, 2017 | 72,000.00 |
| Sep 30, 2017 | -145,000.00 |
| Sep 30, 2017 | -145,000.00 |
| Jun 30, 2017 | 335,000.00 |
| Jun 30, 2017 | 335,000.00 |
| Mar 31, 2017 | -2.59 Mn |
| Mar 31, 2017 | -2.59 Mn |
| Dec 31, 2016 | 2.72 Mn |
| Dec 31, 2016 | 2.72 Mn |
| Sep 30, 2016 | 303,000.00 |
| Sep 30, 2016 | 303,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Mar 31, 2016 | -424,000.00 |
| Mar 31, 2016 | -424,000.00 |
| Dec 31, 2015 | 304,000.00 |
| Dec 31, 2015 | 304,000.00 |
| Sep 30, 2015 | -563,000.00 |
| Sep 30, 2015 | -563,000.00 |